Matt Oguz is the founding partner and Chief Investment Officer of Venture Science. See sector focus and contact routes.
Matt Oguz is the founding partner and Chief Investment Officer of Venture Science, a San Francisco-based venture capital firm he launched in 2012 that pioneers a data-driven, “moneyball” approach to investing [5][6]. His investment thesis targets early-stage companies from pre-seed to Series A, with a recent shift toward mid-to-late stage deals, focusing on AI, quantum computing, deep tech, aerospace, healthcare, energy, and blockchain [1][2][5]. Oguz prefers writing larger checks of several hundred thousand dollars to invest in fewer companies rather than many, typically acting as a lead investor [5]. Notable portfolio companies include Axiom Space, PsiQuantum, Lightmatter, Circle, and Lemonade, with Venture Science also investing in Tala Security and Oxbotica [8][10]. A distinctive point of view central to his strategy is using financial models and quantitative decision principles—such as stochastic finance and multi-factor analysis—to replace heuristics and avoid human bias in venture decisions [3][4][7]. He has publicly written as a columnist for TechCrunch and spoken on cryptocurrency investing and ICO due diligence, advocating for quantifying risk and reward attributes in cut
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in San Francisco.
Investors like Matt Oguz · Full investor directory · Investor access · Company funding database